Several mechanisms for the anticancer effects of DOX in the treatment of thyroid cancer have been proposed, of which inhibition of DNA synthesis by poisoning topoisomerase II (TOP2A) and intercalation with DNA are well described (Pommier et al., 2010; Agudelo et al., 2014; Yang et al., 2014). This evidence concerns the gene TOP2A and thyroid cancer.